Hims & Hers Health, Inc.
NYSE:HIMSMedical - Equipment & Services
+$1.11 today
- Market cap
- $3.85B
- Beta
- 2.40
- P/E (TTM)
- -569.3
- EPS (TTM)
- -$0.06
Volume 9.53M
Average 26.18M
HIMS Total Non-current Assets
All assets not expected to be converted to cash within one year.
Hims & Hers Health, Inc.NYSE: HIMS
Total Non-current Assets · Q3 FY2026 · quarter ended Sep 2026
Total non-current assets rises 60.4% from a year ago
Total non-current assets stood at $2.23B at the end of Q3 FY2026, up 60.4% from a year earlier and down 0.8% from the prior quarter. Over 3 fiscal years it compounded at +110.0% a year.
Context
- Total non-current assets amounted to 62.8% of total assets at the end of Q3 FY2026, up 0.6 pp from a year earlier.
- Total non-current assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps rising in the next quarterly balance sheet after a +60.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.39B USD
- Year-over-year change
- +345.0%
- 4-year CAGR
- +74.2%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.39B | +345.0% |
| FY2024 | 2024-12-31 | 311.71M | +77.0% |
| FY2023 | 2023-12-31 | 176.13M | +17.6% |
| FY2022 | 2022-12-31 | 149.75M | -0.6% |
| FY2021 | 2021-12-31 | 150.68M | — |
Total Non-current Assets vs competitors
How HIMS compares with its peers on the latest reported figures
- HIMS's Sep 2026 total non-current assets of $2.23B is the 6th highest of the 10 companies compared; the peer median is $2.42B.
- Its year-over-year change of +60.4% is the 2nd highest of 10, against a peer median of -17.2%.
- Total non-current assets amounts to 62.8% of total assets for HIMS, versus a peer median of 65.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $20.73B | -2.3% | -0.1% | 77.7% | |
| Sep 2026 | $12.14B | -3.8% | -5.2% | 60.8% | |
| Sep 2026 | $8.18B | -17.2% | -7.9% | 79.0% | |
| Jun 2026 | $5.16B | -31.0% | -11.6% | 67.8% | |
| Mar 2026 | $2.42B | -12.2% | -0.1% | 68.6% | |
| Sep 2026 | $2.23B | +60.4% | +110.0% | 62.8% | |
| Jun 2026 | $1.6B | +124.7% | +76.4% | 65.1% | |
| Feb 2026 | $1.25B | -43.2% | -14.8% | 59.1% | |
| Mar 2026 | $22.11M | -27.9% | -23.6% | 10.3% | |
| Mar 2026 | $18.43M | -22.1% | +9.0% | 26.3% | |
| Peer median (excluding HIMS) | $2.42B | -17.2% | -5.2% | 65.1% | |
Competitors are the stored peer set for HIMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 71.78M | 46.77M | 96.66M | 220.58M | 228.62M |
| Short-term Investments | 175.49M | 132.85M | 124.32M | 79.67M | 348.88M |
| Net Receivables | 3.58M | 3.23M | 6.75M | 6.08M | 32.15M |
| Inventory | 13.56M | 21.56M | 22.46M | 64.43M | 115.73M |
| Other Current Assets | 890K | 1.79M | 4.2M | 8.9M | 4.37M |
| Total Current Assets | 269.91M | 216.6M | 265.05M | 395.83M | 767.64M |
| Property, Plant & Equipment (Net) | 5.11M | 16.14M | 45.73M | 92.96M | 448.98M |
| Goodwill | 110.88M | 110.88M | 110.88M | 112.73M | 278.33M |
| Intangible Assets | 25.89M | 21.84M | 18.57M | 43.41M | 196.12M |
| Long-term Investments | 0 | 0 | 0 | 0 | 351.26M |
| Tax Assets | 0 | 0 | 0 | 61.6M | 82.71M |
| Other Non-current Assets | 8.8M | 889K | 947K | 1M | 29.68M |
| Total Non-current Assets | 150.68M | 149.75M | 176.13M | 311.71M | 1.39B |
| Total Assets | 420.59M | 366.34M | 441.19M | 707.54M | 2.15B |
| Account Payables | 19.64M | 32.36M | 43.07M | 91.18M | 143.28M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 954K | 963K | 2.01M | 0 | 0 |
| Deferred Revenue | 3.19M | 1.47M | 7.73M | 75.29M | 127.16M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 3.65M |
| Total Current Liabilities | 79.22M | 47.94M | 88.47M | 221.37M | 404.43M |
| Long-term Debt | 0 | 0 | 0 | 0 | 972.58M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 28.86M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.63M | 3.01M | 22K | 0 | 64.74M |
| Total Non-current Liabilities | 6.75M | 6.66M | 8.69M | 9.46M | 1.21B |
| Total Liabilities | 85.97M | 54.6M | 97.16M | 230.82M | 1.61B |
| Common Stock | 20K | 21K | 21K | 22K | 23K |
| Retained Earnings | (278.95M) | (344.63M) | (368.18M) | (242.14M) | (113.77M) |
| Accumulated OCI | (137K) | (277K) | (124K) | (324K) | 2.29M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 334.62M | 311.74M | 344.03M | 476.72M | 540.93M |
| Total Debt | 5.48M | 5.31M | 9.95M | 11.35M | 1.12B |
| Net Debt | (66.3M) | (41.47M) | (86.72M) | (209.24M) | 891.97M |
Hims & Hers Health, Inc.
NYSE:HIMS
Intrinsic Alpha fair value
Locked
Current Price
$17.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.